1. Home
  2. Labeler Index
  3. Msn Laboratories Private Limited
  4. 69539-152
  5. NDC Package Code: 69539-152-30 Toremifene Citrate

NDC Package 69539-152-30 Toremifene Citrate

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69539-152-30
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
69539-152
Proprietary Name:
Toremifene Citrate
Non-Proprietary Name:
Toremifene Citrate
Substance Name:
Toremifene Citrate
Usage Information:
Toremifene is used in postmenopausal women to treat breast cancer. It is usually used to treat cancer that needs estrogen, a female hormone, in order to grow (estrogen-receptor positive). Toremifene is a nonsteroidal antiestrogen that blocks the effects of estrogen in the breast tissue, thereby slowing or stopping the growth of cancer.
11-Digit NDC Billing Format:
69539015230
NDC to RxNorm Crosswalk:
  • RxCUI: 313428 - toremifene citrate 60 MG Oral Tablet
  • RxCUI: 313428 - toremifene 60 MG Oral Tablet
  • RxCUI: 313428 - toremifene (as toremifene citrate 88.5 MG) Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Msn Laboratories Private Limited
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • TOREMIFENE CITRATE 60 mg/1
    • Pharmacologic Class(es):
  • Estrogen Agonist/Antagonist - [EPC] (Established Pharmacologic Class)
  • Selective Estrogen Receptor Modulators - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA212818
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    08-20-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69539-152-30?

    The NDC Packaged Code 69539-152-30 is assigned to a package of 30 tablet in 1 bottle of Toremifene Citrate, a human prescription drug labeled by Msn Laboratories Private Limited. The product's dosage form is tablet and is administered via oral form.

    Is NDC 69539-152 included in the NDC Directory?

    Yes, Toremifene Citrate with product code 69539-152 is active and included in the NDC Directory. The product was first marketed by Msn Laboratories Private Limited on August 20, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69539-152-30?

    The 11-digit format is 69539015230. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-269539-152-305-4-269539-0152-30